Your browser doesn't support javascript.
loading
Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function.
Chambers, Pinkie; Watson, Matthew; Bridgewater, John; Forster, Martin D; Roylance, Rebecca; Burgoyne, Rebecca; Masento, Sebastian; Steventon, Luke; Harmsworth King, James; Duncan, Nick; Al Moubayed, Noura.
Afiliação
  • Chambers P; UCL School of Pharmacy, London, UK.
  • Watson M; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK.
  • Bridgewater J; Department of Computer Science, Durham University, Durham, UK.
  • Forster MD; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK.
  • Roylance R; UCL Cancer Institute, London, UK.
  • Burgoyne R; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK.
  • Masento S; UCL Cancer Institute, London, UK.
  • Steventon L; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK.
  • Harmsworth King J; UCL Cancer Institute, London, UK.
  • Duncan N; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK.
  • Al Moubayed N; UCL Cancer Institute, London, UK.
Cancer Med ; 12(17): 17856-17865, 2023 09.
Article em En | MEDLINE | ID: mdl-37610318

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bilirrubina / Aprendizado de Máquina Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bilirrubina / Aprendizado de Máquina Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido